Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
42.10
+0.22 (0.53%)
Nov 17, 2026, 3:00 PM CST
SHA:688050 Revenue
Eyebright Medical Technology (Beijing) had revenue of 519.70M CNY in the quarter ending September 30, 2026, with 45.28% growth. This brings the company's total for the last twelve months to 1.79B, up 21.06% year-over-year. In the year 2025, Eyebright Medical Technology (Beijing) had annual revenue of 1.48B with 5.15% growth. That makes Eyebright Medical Technology (Beijing) the 15,363rd largest company in the world by revenue and 2,769th in China.
Revenue (ttm)
1.79B
Revenue Growth
+21.06%
P/S Ratio
4.55
Revenue / Employee
768.23K
Employees
2,657
Market Cap
8.14B
Revenue by Geography
- China 1.38B 92.9%
- Overseas 105.48M 7.1%
Fiscal year ended Dec 31, 2025 See the full SHA:688050 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.48B | 72.68M | 5.15% |
| Dec 31, 2024 | 1.41B | 458.85M | 48.24% |
| Dec 31, 2023 | 951.18M | 371.68M | 64.14% |
| Dec 31, 2022 | 579.50M | 146.43M | 33.81% |
| Dec 31, 2021 | 433.07M | 160.02M | 58.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Blue Sail Medical | 6.98B |
| Truking Technology | 5.89B |
| Tofflon Science and Technology Group | 5.15B |
| Zhonghong Pulin Medical Products | 2.75B |
| Autek China | 1.82B |
| Sansure Biotech | 1.65B |
| Aidite (Qinhuangdao) Technology | 1.16B |
| Mingyue Optical Lens | 931.08M |